The U.S. Food and Drug Administration has issued a warning letter to a CBD manufacturer based in the UK for making claims that its... FDA sends warning letter to UK CBD company over coronavirus claims

The U.S. Food and Drug Administration has issued a warning letter to a CBD manufacturer based in the UK for making claims that its products could prevent or treat coronavirus infections.

The letter was sent to London-based Nova Botanix LTD, which sells CBD products under the brand CanaBD, on Thursday.

It was the latest in a series of FDA warning letters sent to CBD manufacturers and retailers in connection with Covid-19 claims.

Because the CanaBD website offers CBD products for sale in the United States, the FDA said the company’s claims violated U.S. regulations and warranted the warning letter.

The FDA cited statements made on the CanaBD website that “finding relief from an incurable virus is just within reach in the form of CBD oil,” and that “CBD oil may help to prevent getting infected by strengthening your immune system” and “has also been proven to offer relief to some of the symptoms.”

The letter gave the company 48 hours to respond with the actions it has taken to correct the violations or else risk legal action.

Nova Botanix did not immediately responded to request for comment from Hemp Industry Daily on the warning.

Subscribe to our Newsletter

.LV_validation_message{ font-weight:bold; margin: 0 0 0 5px; } .LV_valid{ color:#00CC00; display:none; } .LV_invalid{ color:#CC0000; font-size:10px; } .LV_valid_field, input.LV_valid_field:hover, input.LV_valid_field:active, textarea.LV_valid_field:hover, textarea.LV_valid_field:active { outline: 1px solid #00CC00; } .LV_invalid_field, input.LV_invalid_field:hover, input.LV_invalid_field:active, textarea.LV_invalid_field:hover, textarea.LV_invalid_field:active { outline: 1px solid #CC0000; }

MJ Shareholders avatar

MJ Shareholders

MJShareholders.com is the largest dedicated financial network and leading corporate communications firm serving the legal cannabis industry. Our network aims to connect public marijuana companies with these focused cannabis audiences across the US and Canada that are critical for growth: Short and long term cannabis investors Active funding sources Mainstream media Business leaders Cannabis consumers

No comments so far.

Be first to leave comment below.

( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )